Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A. Corren J, et al. Among authors: jagerschmidt a. J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526. doi: 10.1016/j.jaip.2019.08.050. Epub 2019 Sep 12. J Allergy Clin Immunol Pract. 2020. PMID: 31521831 Free article. Clinical Trial.
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.
Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, Peters AT, Pavord ID, Ford LB, Sher L, Rabe KF, Rice MS, Rowe P, Lu Y, Harel S, Jagerschmidt A, Khan AH, Kamat S, Pirozzi G, Amin N, Ruddy M, Graham NMH, Mannent LP, Teper A. Maspero JF, et al. Among authors: jagerschmidt a. J Allergy Clin Immunol Pract. 2020 Feb;8(2):527-539.e9. doi: 10.1016/j.jaip.2019.07.016. Epub 2019 Jul 24. J Allergy Clin Immunol Pract. 2020. PMID: 31351189 Free article. Clinical Trial.
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis.
Busse WW, Maspero JF, Lu Y, Corren J, Hanania NA, Chipps BE, Katelaris CH, FitzGerald JM, Quirce S, Ford LB, Rice MS, Kamat S, Khan AH, Jagerschmidt A, Harel S, Rowe P, Pirozzi G, Amin N, Ruddy M, Graham NMH, Teper A. Busse WW, et al. Among authors: jagerschmidt a. Ann Allergy Asthma Immunol. 2020 Nov;125(5):565-576.e1. doi: 10.1016/j.anai.2020.05.026. Epub 2020 May 28. Ann Allergy Asthma Immunol. 2020. PMID: 32474156 Free article. Clinical Trial.
Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.
Allanore Y, Distler O, Jagerschmidt A, Illiano S, Ledein L, Boitier E, Agueusop I, Denton CP, Khanna D. Allanore Y, et al. Among authors: jagerschmidt a. Arthritis Rheumatol. 2018 Oct;70(10):1634-1643. doi: 10.1002/art.40547. Epub 2017 Nov 6. Arthritis Rheumatol. 2018. PMID: 29732731 Free article. Clinical Trial.
Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.
Ledein L, Léger B, Dees C, Beyer C, Distler A, Vettori S, Boukaiba R, Bidouard JP, Schaefer M, Pernerstorfer J, Ruetten H, Jagerschmidt A, Janiak P, Distler JHW, Distler O, Illiano S. Ledein L, et al. Among authors: jagerschmidt a. Br J Pharmacol. 2020 Sep;177(18):4296-4309. doi: 10.1111/bph.15190. Epub 2020 Aug 5. Br J Pharmacol. 2020. PMID: 32627178 Free PMC article.
Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab.
Gayvert K, Desrosiers M, Laidlaw TM, Mannent LP, Patel K, Horowitz J, Amin N, Jagerschmidt A, Hamilton JD, Lim WK, Harel S. Gayvert K, et al. Among authors: jagerschmidt a. J Allergy Clin Immunol. 2024 Sep;154(3):619-630. doi: 10.1016/j.jaci.2024.05.030. Epub 2024 Jun 14. J Allergy Clin Immunol. 2024. PMID: 38880251 Free article. Clinical Trial.
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
Bachert C, Gevaert P, Lipworth B, Mustafa SS, Lane AP, Mullol J, Rowe P, Deniz Y, Kamat S, Khan AH, Jacob-Nara J, Siddiqui S, Ruddy M, Laws E, Msihid J, Harel S, Jagerschmidt A, Amin N, Mannent L, Rout R. Bachert C, et al. Among authors: jagerschmidt a. Allergy. 2024 Oct;79(10):2858-2861. doi: 10.1111/all.16189. Epub 2024 Jun 8. Allergy. 2024. PMID: 38850227 No abstract available.
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Bachert C, Laidlaw TM, Cho SH, Mullol J, Swanson BN, Naimi S, Classe M, Harel S, Jagerschmidt A, Laws E, Ruddy M, Praestgaard A, Amin N, Mannent LP. Bachert C, et al. Among authors: jagerschmidt a. Ann Otol Rhinol Laryngol. 2023 Dec;132(12):1649-1661. doi: 10.1177/00034894231176334. Epub 2023 Jun 15. Ann Otol Rhinol Laryngol. 2023. PMID: 37322842 Free PMC article.
15 results